GH Research (GHRS) Other Working Capital Changes (2022 - 2025)
GH Research (GHRS) posted quarterly Other Working Capital Changes of -$66000.0 for Q4 2025, up 40.54% year-over-year from -$46961.5 in Q4 2024, and down 320.0% quarter-over-quarter from $30000.0 in Q3 2025.
GH Research (GHRS) Other Working Capital Changes (2022 - 2025) Analysis & Trends
GH Research's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$66000.0 for Q4 2025.
- In Q4 2025, Other Working Capital Changes rose 40.54% year-over-year to -$66000.0; the TTM figure through Dec 2025 stood at -$4000.0 (up 97.59% YoY), while the FY2025 annual figure was $42000.0, down 36.36% from the prior year.
- Other Working Capital Changes for Q4 2025 stood at -$66000.0, down from $30000.0 in the prior quarter.
- The five-year high for Other Working Capital Changes was $217000.0 in Q2 2023, with the low at -$111000.0 in Q4 2024.
- The 4-year median for Other Working Capital Changes is -$2000.0 (2023), against an average of $26769.2.
- The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes slumped 5450.0% in 2024, then soared 1600.0% in 2025.
- GH Research's Other Working Capital Changes stood at $121000.0 in 2022, then slumped by 101.65% to -$2000.0 in 2023, then plunged by 5450.0% to -$111000.0 in 2024, then jumped by 40.54% to -$66000.0 in 2025.
- Business Quant data shows GHRS's Other Working Capital Changes at -$66000.0 in Q4 2025, $30000.0 in Q3 2025, and $13000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | GH Research | 2.02 Bn | 1.68 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -66,000.00 |
| Dec 31, 2025 | -66,000.00 |
| Dec 31, 2025 | -66,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Sep 30, 2025 | 30,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 13,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Mar 31, 2025 | 19,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Dec 31, 2024 | -111,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -3,000.00 |
| Jun 30, 2024 | -3,000.00 |